Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus

被引:2
作者
Ozmen, B
Ozmen, D [1 ]
Turgan, N
Habif, S
Mutaf, I
Bayindir, O
机构
[1] Ege Univ, Sch Med, Dept Clin Biochem, TR-35100 Izmir, Turkey
[2] Celal Bayar Univ, Sch Med, Dept Endocrinol, Manisa, Turkey
关键词
diabetes mellitus type 2; homocysteine; cystatin C; microalbuminuria; renal function;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Homocysteinemia is an independent risk factor for cardiovascular disease, but information on its association with type 2 diabetes and mild renal dysfunction is limited. Plasma total homocysteine (tHcy) concentration is partly determined by renal plasma clearance. Serum cystatin C (Cys C) concentration has been introduced as a marker of renal function, specifically as an indicator of glomerular filtration rate (GFR). The aim of this study was to explore the relationships among tHcy, creatinine clearance (Ccr), serum Cys C, and microalbuminuria in a population with type 2 diabetes. Fasting plasma tHcy, serum homocysteine-related vitamins (folate and vitamin B 12), serum Cys C, serum creatinine, urine microalbumin, and creatinine clearance were determined in 75 type 2 diabetic patients and 40 healthy control subjects. The patients were assigned to two groups based on urinary albumin excretion (UAE): normoalbuminuric (NAU, UAE <30 mg/24 hr, n = 35) and microalbuminuric (MAU, UAE 30-300 mg/24 hr, n = 40). Ccr was calculated using the Cockroft-Gault formula. Plasma Hcy levels were determined by HPLC with fluorescence detection and serum Cys C by automated particle enhanced immunoturbidimetry. Plasma tHcy levels were significantly higher in normoalbuminuric and microalbuminuric patients than in controls (10.64+/-0.53, 13.29+/-0.78, 6.91+/-0.37 mmol/L, respectively). Serum Cys C levels in microalbuminuric diabetics were higher than in normoalbuminurics and controls (1.36+/-0.06, 1.12+/-0.04, 1.10+/-0.06 mg/L, respectively). Positive correlations were noted between tHcy and Cys C levels in normoalbuminuric and microalbuminuric diabetics (r = 0.72, r = 0.64, respectively). Homocysteine and creatinine concentrations were correlated in both diabetic groups (r = 0.89, r = 0.93, NAU and MAU, respectively). Elevated plasma total homocysteine concentrations in type 2 diabetics suggest an association between homocysteinemia and deterioration of renal function, evidenced by increased serum creatinine and Cys C, Ccr, and microalbuminuria. These findings implicate homocysteinemia in the relationship between diabetic nephropathy and cardiovascular complications of diabetes.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 43 条
[1]   Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease [J].
Abdella, N ;
Mojiminiyi, OA ;
Akanji, AO .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 50 (03) :177-185
[2]   LACK OF ASSOCIATION BETWEEN PLASMA HOMOCYSTEINE LEVELS AND MICROANGIOPATHY IN TYPE-1 DIABETES-MELLITUS [J].
AGARDH, CD ;
AGARDH, E ;
ANDERSSON, A ;
HULTBERG, B .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1994, 54 (08) :637-641
[3]  
Aras O, 2001, CLIN CHEM, V47, P1263
[4]   The effect of reduced glomerular filtration rate on plasma total homocysteine concentration [J].
Arnadottir, M ;
Hultberg, B ;
NilssonEhle, P ;
Thysell, H .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1996, 56 (01) :41-46
[5]  
Baliga B S, 2000, Endocr Pract, V6, P435
[6]   NET UPTAKE OF PLASMA HOMOCYSTEINE BY THE RAT-KIDNEY IN-VIVO [J].
BOSTOM, A ;
BROSNAN, JT ;
HALL, B ;
NADEAU, MR ;
SELHUB, J .
ATHEROSCLEROSIS, 1995, 116 (01) :59-62
[7]  
Bostom AG, 1999, J AM SOC NEPHROL, V10, P164
[8]   Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine [J].
Bostom, AG ;
Bausserman, L ;
Jacques, PF ;
Liaugaudas, G ;
Selhub, J ;
Rosenberg, IH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (09) :2241-2244
[9]   Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes [J].
Bostom, AG ;
Lathrop, L .
KIDNEY INTERNATIONAL, 1997, 52 (01) :10-20
[10]  
BRATTSTROM L, 1994, J INTERN MED, V236, P631